App Blog - PursueCare
September 23, 2020

PursueCare CEO, Nick Mercadante, featured on Riderflex podcast

PursueCare CEO, Nick Mercadante, featured on Riderflex podcast Nicholas Mercadante, Founder and CEO; PursueCare was featured on the Riderflex podcast and gives an overview of what PursueCare is in this clip. Telemedicine and Telehealth companies are doing incredible things for patients who need treatment but find it difficult to visit […]
June 24, 2020

Substance Use Disorder and Treatment in the LGBTQ Community

Substance Use Disorder and Treatment in the LGBTQ Community June is National Pride Month, making it a good time to raise awareness of the unique issues faced by the LGBTQ community when it comes to substance use disorder as well as the obstacles faced when seeking treatment. While addiction can […]
April 17, 2020

COVID-19 and Substance Use Disorder

COVID-19 and Substance Use Disorder COVID-19 named by WHO for Novel coronavirus NCP concept. Doctor or lab technician holding blood sample with novel (new) coronavirus N.C.P. in Wuhan, Hubei Province, China, medical and healthcareAs coronavirus, or COVID-19, continues to spread there are parts of the population who run a higher […]
March 16, 2020

Staying Safe from Coronavirus (COVID-19)

Staying Safe from Coronavirus (COVID-19) The potential public health threat posed by COVID-19 is very high. U.S. state and federal health authorities are recommending that everyone prepare for the possibility of a coronavirus outbreak in their community. People with opioid use disorder (OUD), methamphetamine use disorder, and those who smoke […]
October 7, 2019

What are Opioids & Opioid Addiction?

What are Opioids & Opioid Addiction? Opioids are a class of drugs that are commonly prescribed to treat pain. Opioids include both opiates (drugs derived from the opium poppy, including morphine, codeine, heroin, and opium) and synthetic opioids like hydrocodone, oxycodone, and methadone, which have similar effects.[1] Common prescription opioids include: […]
July 25, 2019

Reading The Play: How To Identify and Prevent Opioid Dependency In Athletes

Reading The Play: How To Identify and Prevent Opioid Dependency In Athletes It’s a story that is becoming more and more familiar in today’s society. A promising young athlete’s life is destroyed due to Opioid Use Disorder. It’s all too sad, and throughout the country many of us may directly […]
April 10, 2019

Opioids and the Brain

Opioids and the Brain Opioids are powerful drugs that act on the central nervous system in order to provide pain relief. The Drug Enforcement Administration (DEA) classifies most commercially available opioids as Schedule II controlled substances. This means that drugs such as morphine, fentanyl, oxycodone or hydromorphone are considered to […]
February 14, 2019

Study reveals increased restrictions on coverage of buprenorphine for Medicare Part D plans

Study reveals increased restrictions on coverage of buprenorphine for Medicare Part D plans By Dr. Jessica Badichek, PharmD A recent study published in JAMA, the Journal of the American Medical Association, summarized findings on the coverage of buprenorphine under Medicare Part D. Buprenorphine and buprenorphine combined with naloxone is one […]
January 29, 2019

FDA supports development of over-the-counter naloxone

FDA supports development of over-the-counter naloxone By Dr. Jessica Badichek, PharmD A recent statement from FDA Commissioner Dr. Scott Gottlieb summarized the FDA’s new efforts in encouraging drug manufacturers to develop an over-the-counter version of naloxone, the opioid overdose treatment. The FDA stated that the number of overdose deaths involving […]
January 4, 2019

Drug Overdoses linked to Synthetic Opioids

Drug Overdoses linked to Synthetic Opioids By Dr. Jessica Badichek, PharmD According to CDC analysis of the latest drug overdose death data, there were 63,632 drug overdose deaths in the United States in 2016. This was calculated as a 21.4% increase from 2015 data and the largest increase was from […]